Apap

Description

This product is available in two National Drug Code (NDC) formats: 54738-540-01, which contains 100 tablets of acetaminophen (APAP) at a dosage of 500 mg per tablet, and 54738-540-03, which contains 1000 tablets of acetaminophen (APAP) at the same dosage of 500 mg per tablet. Acetaminophen is a widely used analgesic and antipyretic agent.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including headache, muscular aches, backache, minor pain of arthritis, the common cold, toothache, and premenstrual and menstrual cramps. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and over are advised to take 2 caplets every 6 hours as needed for symptom relief. The maximum dosage should not exceed 6 caplets within a 24-hour period, unless otherwise directed by a healthcare professional. Additionally, this medication should not be used for more than 10 consecutive days unless specifically instructed by a doctor.

For children under 12 years of age, it is recommended to consult a healthcare professional for appropriate dosing guidance.

Contraindications

Use is contraindicated in patients who exceed the recommended dosage, as this may lead to liver damage. No other contraindications have been identified.

Warnings and Precautions

This product contains acetaminophen, which poses a significant risk of liver damage if not used according to the specified guidelines. The maximum recommended daily dosage is 6 caplets (3,000 mg) within a 24-hour period. Severe liver injury may occur if the following conditions are met: exceeding 4,000 mg of acetaminophen in a 24-hour period, concomitant use with other medications containing acetaminophen, or consumption of three or more alcoholic beverages daily while using this product.

Healthcare professionals should advise patients against using this product in conjunction with any other medications that contain acetaminophen, whether prescription or over-the-counter. If there is uncertainty regarding the acetaminophen content of a medication, patients should consult a healthcare provider or pharmacist. Additionally, this product should not be used by individuals with a known allergy to acetaminophen or any of the inactive ingredients present in the formulation.

Patients with liver disease should seek medical advice prior to using this product. Furthermore, it is essential to consult a healthcare professional or pharmacist before use if the patient is currently taking warfarin, a blood-thinning medication, due to potential interactions.

Patients are advised to discontinue use and contact a healthcare provider if any of the following occur: pain worsens or persists for more than 10 days, fever intensifies or lasts longer than 3 days, redness or swelling develops, or new symptoms arise, as these may indicate a serious underlying condition.

In the event of an overdose, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay. Prompt medical intervention is crucial for both adults and children, even if no immediate signs or symptoms of overdose are apparent.

Side Effects

Patients using this product should be aware of the potential for serious adverse reactions, particularly related to liver health. The product contains acetaminophen, and exceeding the maximum daily dose of 6 caplets (3,000 mg) within 24 hours may lead to severe liver damage. This risk is heightened if patients consume more than 4,000 mg of acetaminophen in a 24-hour period, use other medications containing acetaminophen, or consume three or more alcoholic drinks daily while using this product.

Patients are advised not to use this product in conjunction with any other drug containing acetaminophen, whether prescription or non-prescription. Individuals with known allergies to acetaminophen or any inactive ingredients in this product should also refrain from use.

Before using this product, patients with liver disease should consult a healthcare professional. Additionally, those taking the blood-thinning medication warfarin are encouraged to seek advice from a doctor or pharmacist prior to use.

Patients should discontinue use and consult a healthcare provider if they experience worsening pain that lasts more than 10 days, a fever that persists for more than 3 days, the presence of redness or swelling, or the emergence of new symptoms, as these may indicate a serious underlying condition.

For pregnant or breastfeeding individuals, it is recommended to seek guidance from a health professional before using this product.

Drug Interactions

Patients taking the anticoagulant warfarin should consult a healthcare professional prior to initiating treatment with this medication. The interaction between this drug and warfarin may necessitate careful monitoring of coagulation parameters to avoid potential adverse effects related to increased bleeding risk. Adjustments to the dosage of warfarin may be required based on the clinical judgment of the healthcare provider.

Packaging & NDC

Below are the non-prescription pack sizes of Apap (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended dosage is 2 caplets every 6 hours as needed, with a maximum of 6 caplets in a 24-hour period, unless otherwise directed by a physician. Treatment should not exceed 10 days without medical advice.

In the event of an overdose, prompt medical attention is essential for both pediatric and adult patients, even if no signs or symptoms are immediately apparent.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is essential to evaluate the potential risks and benefits associated with the use of this drug during pregnancy and lactation. Healthcare providers can offer guidance based on individual circumstances and the latest clinical data.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment should exercise caution when using this product, as it contains acetaminophen. The maximum daily dose is limited to 6 caplets (3,000 mg) within a 24-hour period. It is critical to note that severe liver damage may occur if the total daily intake of acetaminophen exceeds 4,000 mg, whether from this product or from other medications containing acetaminophen. Additionally, consumption of 3 or more alcoholic drinks per day while using this product may further increase the risk of liver damage.

Patients with known liver disease are advised to consult a healthcare professional prior to using this product to assess the appropriateness of treatment and to discuss potential risks associated with acetaminophen use. Regular monitoring of liver function may be warranted in these patients to ensure safety and efficacy.

Overdosage

In the event of overdosage, it is critical to recognize the potential risks associated with excessive intake of this product. The maximum recommended daily dose is 6 caplets, equating to 3,000 mg within a 24-hour period. Exceeding this dosage can lead to serious health complications.

Risk of Severe Liver Damage

Healthcare professionals should be aware that severe liver damage may occur if an individual ingests more than 4,000 mg of acetaminophen within a 24-hour timeframe. Additionally, the risk of liver damage is heightened when acetaminophen is taken concurrently with other medications that also contain acetaminophen.

Furthermore, patients who consume three or more alcoholic beverages daily while using this product are at an increased risk for severe liver damage. It is essential to evaluate a patient's alcohol consumption habits when assessing the risk of acetaminophen-related hepatotoxicity.

Recommended Actions

In cases of suspected overdosage, immediate medical attention is warranted. Healthcare providers should initiate appropriate management procedures, which may include monitoring liver function tests and considering the administration of N-acetylcysteine as an antidote, depending on the severity of the overdose and the time elapsed since ingestion. Prompt intervention is crucial to mitigate the risk of irreversible liver damage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion.

Patients should be informed about the risks associated with overdose. It is crucial to communicate that taking more than the recommended dose may lead to liver damage. In the event of an overdose, patients must seek medical help or contact a Poison Control Center immediately. Emphasize the importance of quick medical attention for both adults and children, even if no signs or symptoms are initially apparent.

Storage and Handling

The product is supplied in a configuration that includes a tamper-evident seal. It is essential to ensure that the safety seal under the cap is intact; do not use the product if the seal is broken or missing.

For optimal storage, the product should be maintained at a temperature range of 15-30 °C (59-86 °F). Proper adherence to these storage conditions is crucial to ensure the integrity and efficacy of the product.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Apap, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)